OliX Pharmaceuticals (XKRX:226950) Ending Cash Position : ₩11,983 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OliX Pharmaceuticals Ending Cash Position?

OliX Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩11,983 Mil.

OliX Pharmaceuticals's quarterly Ending Cash Position increased from Jun. 2023 (₩6,684 Mil) to Sep. 2023 (₩7,029 Mil) and increased from Sep. 2023 (₩7,029 Mil) to Dec. 2023 (₩11,983 Mil).

OliX Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 (₩34,337 Mil) to Dec. 2022 (₩4,930 Mil) but then increased from Dec. 2022 (₩4,930 Mil) to Dec. 2023 (₩11,983 Mil).

OliX Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for OliX Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OliX Pharmaceuticals Ending Cash Position Chart

OliX Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

4,954.47

11,328.81

34,336.74

4,930.27

11,982.76

OliX Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															4,930.27	8,046.63	6,684.41	7,029.00	11,982.76

OliX Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

OliX Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4930.267	+	7052.495
	=	11,983

OliX Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7028.997	+	4953.765
	=	11,983

OliX Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of OliX Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

OliX Pharmaceuticals (XKRX:226950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OliX Pharmaceuticals Inc (XKRX:226950) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226

Website

http://www.olixpharma.com

OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

OliX Pharmaceuticals (XKRX:226950) Headlines

No Headlines